Clinical Trials Logo

Pre-diabetes clinical trials

View clinical trials related to Pre-diabetes.

Filter by:

NCT ID: NCT01326533 Completed - Pre-diabetes Clinical Trials

Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes

Start date: March 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the short-term effects of the antimalarial medication, hydroxychloroquine (HCQ), compared with placebo using frequently sampled intravenous glucose tolerance testing (FSIGTT) methodology to study changes in insulin secretion and glucose tolerance in subjects at risk for developing Type 2 diabetes.

NCT ID: NCT01301521 Completed - Diabetes Clinical Trials

Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics

Cinnamon
Start date: June 11, 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to assess whether water-soluble cinnamon extract plus aggressive lifestyle intervention is effective in lowering blood glucose in pre-diabetic patients when compared to aggressive lifestyle therapy plus placebo.

NCT ID: NCT01301339 Completed - Diabetes Clinical Trials

A1c FIT TEST: An Epidemiological Study Correlating Hemoglobin A1c With Results of the Air Force Physical FITness TEST.

Start date: July 2011
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the prevalence of pre-diabetes and diabetes among those Air Force personnel who have not passed the Air Force physical fitness test (AFPT) and to evaluate the usefulness of the AFPT as a prescreening tool for these disease processes.

NCT ID: NCT01286922 Completed - Pre-diabetes Clinical Trials

The Insulin Sensitivity Using Aerobic Interval Conditioning

ISAIC
Start date: July 2009
Phase: N/A
Study type: Interventional

The Insulin Sensitivity using Aerobic Interval Conditioning (ISAIC) trial will compare traditional aerobic training (AER) to interval training (INT) in sedentary, overweight/obese men at risk for pre-diabetes. The investigators will randomly assign 42 individuals to 3 months of monitored exercise using a randomly assisgned design where participants will exercise under either AER or INT training conditions. The AER training condition will be consistent with "standard-of-care" recommendations. Exercise training will entail one 3-month blocks of either AER or INT. Training will consist of 1) a 1-month ramp up period, 2) 1-month of traditional aerobic training and 3) 1-month of either continued AER or INT.

NCT ID: NCT01107431 Completed - Pre-diabetes Clinical Trials

Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin

L-Arabinose
Start date: December 2008
Phase: N/A
Study type: Interventional

This study was designed to examine changes in capillary blood glucose and venous insulin levels after a 70 gram oral sucrose challenge with and without simultaneous consumption of a dietary supplement containing L-Arabinose and a patented version of chromium (LA-Cr).

NCT ID: NCT01004848 Completed - Pre-diabetes Clinical Trials

Effectiveness Study of Community-Based, Peer-Led Education on Weight Loss and Diabetes

HEED
Start date: March 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effectiveness of a peer-led community-based lifestyle intervention, versus usual care, in achieving weight loss and prevention of diabetes among overweight adults with pre-diabetes in East Harlem.

NCT ID: NCT00962962 Completed - Pre-Diabetes Clinical Trials

Exercise Dose-Response Effects in Prediabetes

STRRIDE-PD
Start date: July 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effects of different amounts and intensities of aerobic exercise training programs, with and without weight loss, in people who are at risk for diabetes. An additional purpose of the study is to evaluate the factors in the blood and in exercising muscles that contribute to the improvement in those risk factors. This information will be used to improve exercise training guidelines for improving cardiovascular and metabolic health in people with abnormal fasting glucose, also known as prediabetes.

NCT ID: NCT00879801 Completed - Pre-Diabetes Clinical Trials

Genetic Physiopathology and Evolution of Type 2 Diabetes

GENFIEV
Start date: January 2003
Phase: N/A
Study type: Observational

There are few longitudinal studies in the Caucasian population and even less in the Italian population in subjects with impaired glucose regulation to allow: 1. An estimate of the rate of conversion to type 2 diabetes; 2. To identify subjects at risk; and 3. To assess the physiopathologic mechanisms responsible for the conversion. In order to set up a longitudinal study capable of defining the above parameters it is mandatory that the physiological, biochemical, and, genetic markers specific for IGR are identified. The goals of the present research proposal are: 1. To clarify the physiological mechanisms responsible for IGR; 2. To identify the biochemical and beta-cell auto-immune parameters present in IGR; 3. Identify genetic markers. The subjects who will be identified will add up to other 900 individuals who will be recruited as part of a follow-up program sponsored by the Italian Society of Diabetes, specifically designed to assess conversion rate to diabetes.

NCT ID: NCT00876928 Completed - Pre-diabetes Clinical Trials

Vitamin D in Minorities With Prediabetes

Start date: March 2009
Phase: N/A
Study type: Interventional

Vitamin D supplementation in minority subjects with both pre-diabetes and low vitamin D levels will delay the development of diabetes.

NCT ID: NCT00853801 Completed - Type 2 Diabetes Clinical Trials

Integrating Lifestyle Therapy for Diabetes Prevention Into Primary Care

Start date: February 2006
Phase: N/A
Study type: Interventional

An educational intervention in the General Medicine Clinic aimed at both primary care providers (PCPs) and their patients with metabolic syndrome/pre-diabetes (MetSyn/PDM). Improving PCPs ability to detect and manage MetSyn/PDM, as measured by the increased incorporation of MetSyn/PDM into PCPs care plan, and increasing patients' awareness of healthy lifestyle behaviors results in positive patient health behaviors and outcomes.